-
Tatva Chintan Pharma Chem’s IPO opens today
In the grey markets, the share was quoting at Rs 1,783 to Rs 1803 commanding a premium of Rs 710-720 or 66% over its issue price
-
Befriend index funds for equity exposure
Investing only in the top rung of the large cap may give investors a sense of FOMO. Shenoy explains how to overcome the fear
-
GR Infraprojects, Clean Science shares may see robust listings; here’s why
Udaipur-based GR Infraprojects is a leading integrated road engineering, procurement, and construction (EPC) company
-
Zomato IPO: Is FOMO bothering you? Don’t fret
Deepak Shenoy, founder and chief executive, Capitalmind told Money9 that retail investors should avoid IPOs
-
Give IPO rush a miss: Deepak Shenoy
Anchor investors are locked in only for one month and if they exit the investment after the first month, prices are bound to fall, says Shenoy
-
Zomato IPO: Early investors see over 23x returns
With a valuation of Rs 59,623 crore at the upper price band, investors who had backed the startup are set to net hefty returns on their investments
-
Zomato IPO: Hera Pheri, ghee to paratha spice up milieu
Zomato IPO: Culinary banter adds spice to listing frenzy as stakeholders and members of the investing community express their support
-
Nine things to know about Tatva Chintan Pharma Chem’s IPO
The price band for the pharma chemical company has been fixed at Rs 1,073-1,083 per share. The issue opens on July 16 and closes on July 20
-
Clean Science and Technology IPO: Here’s how to check your allotment status
The company is engaged in the business of specialty chemicals such as performance chemicals, pharmaceutical intermediates, and FMCG chemicals
-
Is it a good idea to invest in a loss making IPO?
A loss-making firm can file for IPO. If, its restated losses are not more than the total value of assets
